Hubei Goto Biopharm Co.,Ltd. (300966.SZ)

CNY 17.5

(-0.91%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.44 Billion 2.06 Billion 1.21 Billion 804.42 Million 817.68 Million 615.07 Million
Total Current Assets 869.73 Million 1.21 Billion 858.25 Million 579.64 Million 587.64 Million 429.95 Million
Cash And Short Term Investments 181.97 Million 453.42 Million 210.01 Million 28.96 Million 129.66 Million 65.11 Million
Cash and Cash Equivalents 181.97 Million 438.41 Million 209.91 Million 28.96 Million 129.66 Million 65.11 Million
Short Term Investments 1010.45 15.01 Million 101.18 Thousand - - -
Net Receivables 257.33 Million 307.39 Million 263.09 Million 342.58 Million 205.88 Million 162.55 Million
Inventory 396.15 Million 432.49 Million 371.24 Million 200.73 Million 243.49 Million 194.15 Million
Other Current Assets 34.25 Million 20.4 Million 13.89 Million 7.35 Million 8.6 Million 8.13 Million
Total Non-Current Assets 1.57 Billion 854.58 Million 352.98 Million 224.78 Million 230.03 Million 185.12 Million
Net PPE 1.39 Billion 611.57 Million 257.75 Million 198.1 Million 201.23 Million 166.55 Million
Good Will And Intangible Assets 50.99 Million 43.13 Million 27.82 Million 21.05 Million 21.38 Million 13.39 Million
Good Will - - - - - -
Intangible Assets 50.99 Million 43.13 Million 27.82 Million 21.05 Million 21.38 Million 13.39 Million
Long-Term Investments 48.23 Million 33.06 Million 14.37 Million 2.00 2.00 1.00
Tax Assets 22.62 Million 16.9 Million 8.82 Million 3.43 Million 3.8 Million 2.79 Million
Other Non Current Assets 64.28 Million 149.89 Million 44.21 Million 2.18 Million 3.6 Million 2.37 Million
Other Assets 1.00 - - 1.00 - -
Total Liabilities 1.42 Billion 1.08 Billion 382.82 Million 264.57 Million 336.42 Million 206.82 Million
Total Current Liabilities 686.4 Million 575.96 Million 333.18 Million 247.12 Million 296.54 Million 190.76 Million
Account Payables 532.23 Million 205.52 Million 138.17 Million 74.11 Million 134.21 Million 94.12 Million
Tax Payables 4.08 Million 7.48 Million 11.4 Million 8.25 Million 9.13 Million 9.81 Million
Short Term Debt 132.81 Million 328.84 Million 154.87 Million 139.76 Million 147.32 Million 80.89 Million
Deferred Revenue 16.59 Million 18.95 Million 22.56 Million 12.51 Million 13.37 Million 14.27 Million
Other Current Liabilities 4.75 Million 22.63 Million 17.56 Million 20.72 Million 1.62 Million 1.46 Million
Total Non Current Liabilities 737.55 Million 511.2 Million 49.64 Million 17.45 Million 39.88 Million 16.05 Million
Long-Term Debt 652.91 Million 441.45 Million 6.66 Million 1.31 Million 31.51 Million 8.04 Million
Deferred Revenue Non Current 84.32 Million 69.7 Million 42.98 Million 7.68 Million 8.37 Million 8.01 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 30 Thousand 49.33 Thousand 0.61 9.76 Million 31.51 Million 8.04 Million
Other Liabilities 1.00 - - 1.00 1.00 -
Total Equity 1.02 Billion 981.14 Million 828.41 Million 539.84 Million 481.25 Million 408.25 Million
Stock Holders Equity 952.74 Million 928.07 Million 807.05 Million 534.54 Million 481.25 Million 408.25 Million
Common Stock 115.27 Million 115.27 Million 115.27 Million 86.27 Million 86.27 Million 86.27 Million
Retained Earnings 320.34 Million 297.31 Million 272.8 Million 197.35 Million 145.48 Million 76.15 Million
Accumulated other comprehensive income 96.49 Million 106.36 Million 9.86 Million 6.98 Million 5.56 Million 1.89 Million
Common Stock Equity 952.74 Million 928.07 Million 807.05 Million 534.54 Million 481.25 Million 408.25 Million
Capital Lease Obligation 538.62 Thousand 4.41 Million 6.66 Million 9.74 Million 31.51 Million 8.04 Million
Total Investments 48.23 Million 48.08 Million 14.47 Million 2.00 2.00 1.00
Total Debt 785.72 Million 770.3 Million 161.54 Million 139.76 Million 147.32 Million 80.89 Million
Net Debt 603.75 Million 331.88 Million -48.37 Million 110.8 Million 17.65 Million 15.78 Million

Balance Sheet Charts